422 related articles for article (PubMed ID: 10640312)
1. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Oerther S; Ahlenius S
J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Tarazi FI; Zhang K; Baldessarini RJ
J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
[TBL] [Abstract][Full Text] [Related]
3. Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.
Ahlqvist J; Isacson R; Wahlestedt C; Salmi P
Eur Neuropsychopharmacol; 2003 May; 13(3):177-82. PubMed ID: 12729943
[TBL] [Abstract][Full Text] [Related]
4. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
6. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Deveney AM; Waddington JL
Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
10. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
[TBL] [Abstract][Full Text] [Related]
11. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Ahnaou A; Megens AA; Drinkenburg WH
Neuropsychobiology; 2003; 48(1):47-54. PubMed ID: 12886041
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Tarazi FI; Zhang K; Baldessarini RJ
Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
[TBL] [Abstract][Full Text] [Related]
13. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Kalkman HO; Loetscher E
Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093
[TBL] [Abstract][Full Text] [Related]
14. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
15. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
[TBL] [Abstract][Full Text] [Related]
16. The effects of novel antipsychotics on glucose and lipid levels.
Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
[TBL] [Abstract][Full Text] [Related]
17. Antagonism by pimozide of olanzapine-induced hypothermia.
Ninan I; Kulkarni SK
Fundam Clin Pharmacol; 1999; 13(5):541-6. PubMed ID: 10520726
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
Tarazi FI; Baldessarini RJ; Kula NS; Zhang K
J Pharmacol Exp Ther; 2003 Sep; 306(3):1145-51. PubMed ID: 12829726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
